Researchers at the University of California San Diego (UCSD) have created a molecule, named antisense oligonucleotide (ASO) 56, that is…
Articles by Marisa Wexler, MS
The U.S. government soon will launch a first national study to assess the prevalence of metabolic dysfunction-associated steatotic liver disease,…
A new mutation in the NR1H4 gene was identified as the cause of progressive familial intrahepatic cholestasis type 5…
Technologies to prevent, detect, and treat viral hepatitis have advanced considerably in recent decades, but the number of people…
A nonprofit group has donated $60,000 to support researchers at Yale University School of Medicine working to expand access to…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to DD01 as a potential treatment for a…
A Canadian Agency for Drugs and Technologies in Health (CADTH) committee has recommended that Livmarli (maralixibat) be covered by…
The U.S. Food and Drug Administration (FDA) has again expanded its approval of Gilead Sciences’ medication Vemlidy (tenofovir alafenamide)…
The Phase 3 trial that supported the U.S. approval of Livmarli (maralixibat) for progressive familial intrahepatic cholestasis (PFIC) involved…
Blood vessel abnormalities in the brain, such as unusually narrow or bulging vessels, are common in children with Alagille…